CN102784352A - Agent for treating psoriasis vulgaris - Google Patents

Agent for treating psoriasis vulgaris Download PDF

Info

Publication number
CN102784352A
CN102784352A CN2011101225827A CN201110122582A CN102784352A CN 102784352 A CN102784352 A CN 102784352A CN 2011101225827 A CN2011101225827 A CN 2011101225827A CN 201110122582 A CN201110122582 A CN 201110122582A CN 102784352 A CN102784352 A CN 102784352A
Authority
CN
China
Prior art keywords
grams
radix
water
agent
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011101225827A
Other languages
Chinese (zh)
Inventor
徐显武
石秀琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011101225827A priority Critical patent/CN102784352A/en
Publication of CN102784352A publication Critical patent/CN102784352A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an agent for treating psoriasis vulgaris, and specifically to an external application agent for treating psoriasis vulgaris. A purpose of the present invention is mainly to solve problems of low cure rate and easy recurrence of external application agents for treating psoriasis vulgaris in the prior art. A formula of the agent of the present invention comprises: 5 g of musk, 25 g of borneol, 25 g of radix notoginseng, 50 g of sulfur, 50 g of realgar, 25 g of rheum, 25 g of angelica, 20 g of salvia miltiorrhiza, 18 g of amur corktree bark, 15 g of coptis chinensis, 25 g of frankincense, 25 g of angelica archang lica, 20 g of licorice root, 16 g of weeping forsythia fruit, 17 g of glabrous greenbrier rhizome, 15 g of honeysuckle, 25 g of balloonflower root, 21 g of seasoned orange peel, 13 g of blue turmeric rhizome, 21 g of arborvitae, 9 g of mythic fungus, 17 g of tribulus terrestris, 16 g of tuber fleeceflower root, 22 g of dandelion, and 18 g of folium isatidis. According to the preparation method, the materials in the formula are mixed and added with water, wherein the amount of the water is 10 times the total weight of the materials; boiling is performed for one hour; filtration is performed to obtain the primary resulting drug liquid; water is added to the boiled materials, wherein the amount of the water is 10 times the total weight of the materials; then boiling is performed for one hour; filtration is performed to obtain the secondary resulting drug liquid; and the primary resulting drug liquid and the secondary resulting drug liquid are mixed. The agent of the present invention has advantages of high cure rate and less recurrence.

Description

A kind of pharmaceutical treatment of psoriasis
Technical field:
The present invention relates to a kind of pharmaceutical treatment of psoriasis of external.
Background technology:
Psoriasis is the chronic dermatosis that a kind of common being considered to is difficult to cure; The commercially available psoriasic medicine for external use of treatment has Etretinate cream, wipes tinea liquid and Miao Ling cleansing cream etc. at present; These medicaments all have certain effect on the treatment psoriasis; But the ubiquity cure rate is low, is prone to the problem of recurrence.
Summary of the invention:
It is high that technical problem to be solved by this invention provides a kind of cure rate, is difficult for the pharmaceutical treatment of psoriasis of recurrence.
Above-mentioned purpose is achieved in that gets Moschus 5 grams, Borneolum Syntheticum 25 grams, Radix Notoginseng 25 grams, sulfur 50 grams, Realgar 50 grams, Radix Et Rhizoma Rhei 25 grams, Radix Angelicae Sinensis 25 grams, Radix Salviae Miltiorrhizae 20 grams, Cortex Phellodendri 18 grams, Rhizoma Coptidis 15 grams, Olibanum 25 grams, the Radix Angelicae Dahuricae 25 grams, Radix Glycyrrhizae 20 grams, Fructus Forsythiae 16 grams, Rhizoma Smilacis Glabrae 17 grams, Flos Lonicerae 15 grams, Radix Platycodonis 25 grams, Pericarpium Citri Reticulatae 21 grams, Rhizoma Curcumae 13 grams, Cacumen Platycladi 21 grams, Ganoderma 9 grams, Fructus Atriplicis Sibiricae 17 grams, Radix Polygoni Multiflori 16 grams, Herba Taraxaci 22 grams, Folium Isatidis 18 grams.
Above-mentioned medicament mixes the water that the back adds 10 times of medicament gross weights, boils one hour, and medicinal liquid is leached, and adds the water of 10 times of medicament gross weights again, boils one hour again, and medicinal liquid is leached, and twice gained medicinal liquid is mixed again, and the cool back bottling of drying in the air is for use.Usage: smear the affected part, every day twice, can cure in general 3-4 month.
Advantage of the present invention is, because Realgar, sulfur, Radix Et Rhizoma Rhei, Cortex Phellodendri, Rhizoma Coptidis in the prescription have clearing away heat-fire, parasite killing, detoxifcation, itching-relieving action; Moschus, Borneolum Syntheticum, Radix Notoginseng have clearing heat for detumescence, promoting blood circulation to remove blood stasis effect; The Radix Angelicae Dahuricae, Fructus Forsythiae, Rhizoma Smilacis Glabrae, Flos Lonicerae have dispeiling pathogenic wind and removing dampness, subduing swelling and detoxicating, antibiotic, enhance immunity effect; Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae blood circulation promoting and enriching; Radix Glycyrrhizae is controlled carbuncle sore tumefacting virus; So therapeutic effect is good, cure rate is high, is difficult for recurrence.
The specific embodiment:
Get Moschus 5 grams, Borneolum Syntheticum 25 grams, Radix Notoginseng 25 grams, sulfur 50 grams, Realgar 50 grams, Radix Et Rhizoma Rhei 25 grams, Radix Angelicae Sinensis 25 grams, Radix Salviae Miltiorrhizae 20 grams, Cortex Phellodendri 18 grams, Rhizoma Coptidis 15 grams, Olibanum 25 grams, the Radix Angelicae Dahuricae 25 grams, Radix Glycyrrhizae 20 grams, Fructus Forsythiae 16 grams, Rhizoma Smilacis Glabrae 17 grams, Flos Lonicerae 15 grams, Radix Platycodonis 25 grams, Pericarpium Citri Reticulatae 21 grams, Rhizoma Curcumae 13 grams, Cacumen Platycladi 21 grams, Ganoderma 9 grams, Fructus Atriplicis Sibiricae 17 grams, Radix Polygoni Multiflori 16 grams, Herba Taraxaci 22 grams, Folium Isatidis 18 grams.
Above-mentioned medicament mixes the water that the back adds 10 times of medicament gross weights, boils one hour, and medicinal liquid is leached, and adds the water of 10 times of medicament gross weights again, boils one hour again, and medicinal liquid is leached, and twice gained medicinal liquid is mixed again, and the cool back bottling of drying in the air is for use.Usage: smear the affected part, every day twice, can cure in general 3-4 month.
The present invention can prove through my treatment practice the psoriasis treatment effect: through the 162 routine psoriatics of this human therapy, and whole produce effects after the medication; Healing person's 159 examples are cured and are not had recurrence after 1 year, so effective percentage of the present invention is 100%; Cure rate is 98%, is difficult for recurrence.
In addition, agree that we also once utilized the present invention and at present commercially available treatment psoriasis medicine Seedling spirit commonly used cleansing cream to be the comparative efficacy test to 10 routine psoriatics through the patient.Method is: the part disease sites the patient is treated with the present invention; Treat with Seedling spirit cleansing cream at other disease sites; Treatment through 1-3 month is observed; Cured or focus obviously alleviates with the affected part of the present invention treatment, and alleviating in various degree only arranged with the affected part focus that Seedling spirit cleansing cream is treated.

Claims (1)

1. pharmaceutical treatment of psoriasis is characterized in that: its prescription is Moschus 5 grams, Borneolum Syntheticum 25 grams, Radix Notoginseng 25 grams, sulfur 50 grams, Realgar 50 grams, Radix Et Rhizoma Rhei 25 grams, Radix Angelicae Sinensis 25 grams, Radix Salviae Miltiorrhizae 20 grams, Cortex Phellodendri 18 grams, Rhizoma Coptidis 15 grams, Olibanum 25 grams, the Radix Angelicae Dahuricae 25 grams, Radix Glycyrrhizae 20 grams, Fructus Forsythiae 16 grams, Rhizoma Smilacis Glabrae 17 grams, Flos Lonicerae 15 grams, Radix Platycodonis 25 grams, Pericarpium Citri Reticulatae 21 grams, Rhizoma Curcumae 13 grams, Cacumen Platycladi 21 grams, Ganoderma 9 grams, Fructus Atriplicis Sibiricae 17 grams, Radix Polygoni Multiflori 16 grams, Herba Taraxaci 22 gram, Folium Isatidis 18 gram; Its manufacture method is: above-mentioned medicament is mixed the water that the back adds 10 times of medicament gross weights, boiled one hour, medicinal liquid is leached, add the water of 10 times of medicament gross weights again, boiled one hour again, medicinal liquid is leached, twice gained medicinal liquid mixed again.
CN2011101225827A 2011-05-13 2011-05-13 Agent for treating psoriasis vulgaris Pending CN102784352A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011101225827A CN102784352A (en) 2011-05-13 2011-05-13 Agent for treating psoriasis vulgaris

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101225827A CN102784352A (en) 2011-05-13 2011-05-13 Agent for treating psoriasis vulgaris

Publications (1)

Publication Number Publication Date
CN102784352A true CN102784352A (en) 2012-11-21

Family

ID=47150069

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101225827A Pending CN102784352A (en) 2011-05-13 2011-05-13 Agent for treating psoriasis vulgaris

Country Status (1)

Country Link
CN (1) CN102784352A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103263644A (en) * 2013-04-22 2013-08-28 缪友道 Traditional Chinese medicine for treating neurodermatitis
CN104888012A (en) * 2015-06-17 2015-09-09 青岛海之星生物科技有限公司 Traditional Chinese medicine tincture for treating psoriasis and preparation method of traditional Chinese medicine tincture
CN105250623A (en) * 2015-11-23 2016-01-20 山西大同大学 Method for preparing medicine for treating psoriasis
CN106075219A (en) * 2016-07-28 2016-11-09 刘雨华 One treats psoriasic traditional Chinese biological preparation and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101569730A (en) * 2008-04-30 2009-11-04 徐显武 Traditional Chinese medicine tolnaftate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101569730A (en) * 2008-04-30 2009-11-04 徐显武 Traditional Chinese medicine tolnaftate

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103263644A (en) * 2013-04-22 2013-08-28 缪友道 Traditional Chinese medicine for treating neurodermatitis
CN104888012A (en) * 2015-06-17 2015-09-09 青岛海之星生物科技有限公司 Traditional Chinese medicine tincture for treating psoriasis and preparation method of traditional Chinese medicine tincture
CN105250623A (en) * 2015-11-23 2016-01-20 山西大同大学 Method for preparing medicine for treating psoriasis
CN106075219A (en) * 2016-07-28 2016-11-09 刘雨华 One treats psoriasic traditional Chinese biological preparation and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103463528B (en) Traditional Chinese medicine composition for treating chronic eczema
CN1698745B (en) Externally applied anti-inflammation Chinese medicine composition
CN102018937A (en) Medicament for treating acne and preparation method thereof
CN102973862B (en) Chinese medicine preparation for treating skin itch
CN103933468A (en) Traditional Chinese medicine for treating acute pancreatitis
CN101569730A (en) Traditional Chinese medicine tolnaftate
CN102784352A (en) Agent for treating psoriasis vulgaris
CN103599492B (en) A kind of medicine of Acne treatment
CN103623385B (en) A kind of Chinese medicine for the treatment of oral ulcer
CN102688393B (en) Traditional Chinese medicine for treating verruca plana and preparation method thereof
CN101991794A (en) Chinese traditional medicine preparation for treating eczema
CN104644857A (en) Traditional Chinese medicine formula for treating acnes
CN1883642A (en) Medicine for treating mammary glands hyperplasia
CN103083475A (en) Preparation method for pyogenic osteomyelitis treatment traditional Chinese medicine preparation
CN102895507B (en) Chinese medicine for treating leukoplakia vulvae and preparation method thereof
CN102114235A (en) External Chinese herbal preparation for treating woman lobular hyperplasia of mammary glands and preparation method thereof
CN103919947A (en) Lotion for treating intractable tinea capitis
CN104940816A (en) Traditional Chinese medicine granule for treating cervical spondylosis and preparation method
CN103550460A (en) Traditional Chinese medicine formula for treatment of dysmenorrhoea
CN105343803A (en) Traditional Chinese medicine ointment for treating gynecological inflammation
CN102188554A (en) Tongjingning capsule
CN106729433B (en) Traditional Chinese medicine compound for treating skin carbuncle and swelling and preparation thereof
CN104826043A (en) Chinese medicinal formula for treating crural sprain
CN105497661A (en) Traditional Chinese medicine formula for treating acne
CN104510827A (en) Traditional Chinese medicine for treating acne

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121121